XML 25 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (24,590,375) $ (56,204,313)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 3,836,770 4,628,406
Change in fair value of warrants (3,625,893) 11,837,200
Non-cash other financing costs, including change in fair value of derivative 1,803,189
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 1,079,827 3,190,832
Accounts payable 1,013,138 (2,668,417)
Accrued expenses (1,411,260) (751,012)
Net cash used in operating activities (21,894,604) (39,967,304)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net 18,666,797 16,885,946
Proceeds from exercise of warrants 8,025,003 450,000
Proceeds from exercise of stock options 0 8,385
Net cash provided by financing activities 26,691,800 17,344,331
Net increase (decrease) in cash and cash equivalents 4,797,196 (22,622,973)
Cash and cash equivalents, beginning of year 5,754,720 28,377,693
Cash and cash equivalents, end of year 10,551,916 5,754,720
Supplemental disclosure of cash flow information:    
Other adjustment to value of warrants related to exercises 9,317,108 606,201
Cash paid for financing costs $ 50,000